Prostate cancer radiopharmaceutical therapy: Beyond the basics
45 minVendor WorkshopOnlineOn-site
Prostate cancer radiopharmaceutical therapy: Beyond the basics
About this session
Join Dr. Joseph R. Osborne, MD, PhD from New York-Presbyterian Hospital/Weill Cornell Medicine as he goes beyond the basics in this session on radiopharmaceutical therapy for prostate cancer.
RSNA 2023
Nuclear Medicine
Request information
Share
1 / 0
Joseph R. Osborne
Professor of Radiology; Director of the Radiology Health Equity Lab, New York-Presbyterian Hospital/Weill Cornell Medicine
Speaker
Related products and topics
1 / 0
Molecular Imaging
Discover how our molecular imaging equipment - PET/CT, SPECT, and hybrid SPECT scanner (SPECT/CT) help clinicians diagnose, treat, and monitor disease more confidently.
Theranostics for personalized cancer care
Empowering precision oncology
The Value of Molecular Imaging for Prostate Cancer
Molecular imaging plays an important role in the evaluation of prostate cancer and visualizes the extent of disease and biological response to treatment throughout the continuum of care.